Powered by

A year after buyout, Lilly to shutter Dermira's Menlo Park facility and shed 163 jobs

Apr 14, 2021 - FiercePharma

Eli Lilly is selling Dermira's medicated cloth for excessive sweating, Qbrexza, and plans to shutter Dermira's Menlo Park facility, shedding 163 jobs along the way.

Eli Lilly took a sizable leap into the dermatology market last year with its $1.1 billion acquisition of Dermira, picking up Qbrexza, the medicated cloth for excessive sweating, and a potential rival to Regeneron and Sanofi's atopic dermatitis blockbusterDupixent.

Now, abouta year later, Lilly is selling Qbrexza and plan...